Efficacy of interferons in treating children with chronic hepatitis C

European Journal of Pediatrics

Volumn 156, Issue 9, 1997, Pages 704-708

  Matsuoka, S ^a   Mori, K ^b   Nakano, O ^c   Yuasa, Y ^d   Taguchi, Y ^d   Hayabuchi, Y ^a   Kuroda, Y ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b KOCHI RED CROSS HOSPITAL   (Japan)

^c Takamatsu Municipal Hospital   (Japan)

^d TOKUSHIMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

HCV antibody; HCV genotype; HCV RNA; Post transfusion hepatitis

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON; RECOMBINANT ALPHA2B INTERFERON; VIRUS RNA;

ADOLESCENT; ARTICLE; CHILD; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MALE; PREDICTION; PRIORITY JOURNAL; SCHOOL CHILD; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; VIRUS TYPING;

ADOLESCENT; BIOPSY; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HEART DEFECTS, CONGENITAL; HEPACIVIRUS; HEPATITIS C; HEPATITIS, CHRONIC; HUMANS; INFANT; INJECTIONS, SUBCUTANEOUS; INTERFERON-ALPHA; LIVER; LIVER FUNCTION TESTS; MALE; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATIONS; RNA, VIRAL; TREATMENT OUTCOME; VIRUS ACTIVATION; VIRUS REPLICATION;

EID: 0030921676     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004310050694     Document Type: Article

References (23)

1. Arase Y, Kumada H, Chayama K, Tsubota A, Koide I, Ikeda K, Saitoh S, Matsumoto T, Kobayashi M (1994) Interferon retreatment of nonresponders with HCV-RNA-positive chronic hepatitis C. J Gastroenterol 29:299-304
2. Castilla A, Pieto J, Fausto N (1991) Transforming growth factors beta 1 and alfa in chronic liver disease. Effect of interferon alfa therapy. N Engl J Med 324:933-940
3. Clemente MG, Congia M, Lai ME, Lilliu F, Lampis R, Frau F, Frau R, Faa G, Diana G, Dessi C, Melis A, Mazzoleni AP, Cornacchia G, Cao A, De Virgillis S (1994) Effect of iron overload on the response to recombinant interferon-alfa treatment in transfusion -dependent patients with thalassemia major and chronic hepatitis. J Pediatr 125:123-128
4. Davis GK, Balart LA, Schiff ER, Linsday K, Bodenheimer H, Perillo R, Carey W (1989) Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized, controlled trial. N Engl J Med 321:1501-1506
5. Di Bisceglie AM, Martin P, Kassianides C, Lisker-Melman M, Murray L, Waggoner J, Goodman Z (1989) Recombinant interferon alpha therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. N Engl J Med 321:1506-1519
6. Dusheiko G, Schmilovitz-Weiss H, Brown D, MacOmish F, Yap PL, Sherlock S, McIntyre N, Simmonds P (1994) Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology 19:13-18
7. Fujisawa T, Inui A, Ohkawa T, Komatsu H, Miyakawa Y, Onoue M (1995) Response to interferon therapy in children with chronic hepatitis C. J Pediatr 127:660-662
8. Hagiwara H, Hayashi N, Mita E (1992) Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon. Hepatology 15:1013-1016
9. Kasahara A, Hayashi N, Hiramatsu N, Oshita M, Hagiwara H, Katayama K, Kato M, Masuzawa M, Yoshihara H, Kishida Y, Shimizu Y, Inoue A, Fusamoto H, Kamada T (1995) Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: a multicenter randomized controlled trial. Hepatology 21:291-297
10. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohto M, Omata M (1993) Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease. Hepatology 18:16-20
11. Knodell RG, Ishak KG, Black WC, Chen T, Craig R, Kaplowitz N, Kiernan TW (1981) Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435
12. Kohayashi Y, Watanabe S, Konishi M, Yokoi M, Kakehashi R, Kaito M, Kondo M, Hayashi Y, Tomori T, Suzuki S (1993) Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-beta. Hepatology 18:1319-1325
13. Matsuoka S, Tatara K, Hayabuchi Y, Taguchi Y, Mori K, Honda H, Itoh S, Yuasa Y, Kuroda Y (1994) Serologic, virologic, and histologic characteristics of chronic phase hepatitis C virus disease in children infected by transfusion. Pediatrics 94:919-922
14. Okamoto H (1993) Classification of HCV genotype using type-specific primers in core-region and response to IFN. Nihon Rynshou. 52:1699-1706
15. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T Sato K, Tsuda F, Miyakawa Y, Mayumi M (1992) Typing hepatitis C virus by polymerase chain reaction with type-specific primer: application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679
16. Ruiz-Moreno M, Rua MJ, Castillo I, Garcia-Novo MD, Santos M, Navas S, Carreno V (1992) Treatment of children with chronic hepatitis C with recombinant interferon-alpha: a pilot study. Hepatology 16:882-885
17. Schattner A, Wallach D, Merlin G, Hahn T, Levin S, Revel M (1981) Assay of an interferon-induced enzyme in white blood cells as a diagnostic aid in viral disease. Lancet 11:497-500
18. Shindo M, Di Bisceglie AM, Hoofnagle JH (1992) Long-term follow-up of patients with chronic hepatitis C treated with alpha interferon. Hepatology 15:1013-1016
19. Silini E, Bono F, Cividini A, Cerino A, Bruno S, Rossi S, Belloni G, Brugnetti B, Civardi E, Salvaneschi L, Mondelli MU (1995) Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology 21:285-290
20. Tanaka E, Kiyosawa K, Sodeyama T, Nakano Y, Yoshizawa K, Hayata T, Shimizu S, Nakatsuji Y, Koike Y, Furuta S (1991) Significance of antibody to hepatitis C virus in Japanese patients with viral hepatitis: relationship between anti-HCV antibody and the prognosis of non-A, non-B post-transfusion hepatitis. J Med Virol 33:117-122
21. Yoshioka K, Kakumu S, Wakita T, Ishikawa T, Itoh Y, Takayanagi M, Higashi Y, Shibata M, Morishima T (1992) Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus. Hepatology 16:293-299
22. Yuki N, Hayashi N, Hagiwara H, Takehara T, Katayama K, Kasahara A, Fusamoto H, Kamada T (1993) Quantitative analysis of antibodies to hepatitis C virus during interferon-alpha therapy. Hepatology 17:960-965
23. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi E, Romagnani S, Gentilini O, Brechot C (1992) Infection of peripheral blood mononuclear cells by hepatitis C virus. Hepatology 15:382-386